Johnson Johnson Profile

123.72
USD 0.27  0.22%
23%
23%

Sale by Peterson Per A of 10000 shares of Johnson Johnson

Johnson Johnson insider trading alert for sale of common by Peterson Per A, Executive Committee Member, on May 23, 2018. This event was filed by Johnson Johnson with SEC on 2005-09-19. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Johnson Johnson Summary

Johnson & Johnson are known for their many different products. Odds are if you search your bathroom you will find multiple products made by this company. Solid and sound, the company has been upgraded by Wells Fargo, which is positive news for price movement. As well as that, the company has acquired the company Actelion, which operates in the biotech industry. [more]
Johnson Johnson (JNJ) is traded on New York Stock Exchange in USA. It is located in NEW JERSEY, U.S.A and employs 134,000 people. Johnson Johnson is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with total capitalization of 333.23 B. Johnson Johnson runs under Healthcare sector within Healthcare Products industry. This company has 2.68 B outstanding shares of which 13.21 M shares are currently shorted by investors with about 2.43 days to cover shorted positions. JOHNSON AND JOHNS has about 18.3 B in cash with 18.41 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.82.
Check Johnson Johnson Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 123.72HorizonTargetOdds Above 123.72
22.40%30 days 123.72 77.03%
Based on normal probability distribution, the odds of Johnson Johnson to move above current price in 30 days from now is about 77.03% (This Johnson Johnson probability density function shows the probability of Johnson Johnson Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares207.4 M26.6 B
Blackrock IncCommon Shares175.4 M22.5 B
View Johnson Johnson Diagnostics

Selected Johnson Johnson Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Johnson Johnson Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
12 
Equity ratings for Johnson Johnson are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Johnson Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Johnson Johnson was founded in 1885 and is based in New Brunswick, New Jersey. Johnson Johnson operates under Drug Manufacturers - Major classification in USA and traded on New York Stock Exchange. It employs 134000 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameJohnson Johnson
ChairmanAlex GorskyView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 5 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Healthcare Products
InstrumentUSA Stock View All
RegionNorth America
LocationNEW JERSEY, U.S.A
Business AddressOne Johnson & Johnson Plaza
Foreign Associates
ExchangeNew York Stock Exchange
CIK Number00200406.0
ISINUS4781601046
CUSIP478160104
SectorHealthcare
IndustryHealthcare Products
BenchmarkDOW
Websitewww.jnj.com
Contact Number732 524 0400
CurrencyUSD - US Dollar

Recommendations

Johnson Johnson Analyst Recommendations
Target PriceAdvice# of Analysts
123.93Hold15Odds
Johnson Johnson current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Johnson Johnson Analyst Advice  

Earnings

Johnson Johnson Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.76April 18, 2017
Johnson Johnson normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

Johnson Johnson Corporate Directors
William Perez Independent Director
Ronald Williams Independent Director
Mary Coleman Independent Director
Please also check Risk vs Return Analysis. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.